- Trials with a EudraCT protocol (210)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
210 result(s) found for: Chest Radiograph.
Displaying page 1 of 11.
EudraCT Number: 2006-002098-30 | Sponsor Protocol Number: | Start Date*: 2006-09-04 |
Sponsor Name:Erasmus Medical Centre Rotterdam | ||
Full Title: Efficacy of Inhaled RhDNase in Mechanically Ventilated Pediatric Patients with an Atelectasis | ||
Medical condition: Study population are: Children who develop an atelectasis during mechanical ventilation. An atelectasis is a collapsed part of the lung that is often caused by mucus plugs. | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000658-22 | Sponsor Protocol Number: PROT 1203 | Start Date*: 2005-06-16 |
Sponsor Name:University of Oxford, NDM | ||
Full Title: The Second Multi-Centre Intra-Pleural Sepsis Trial (MIST2), to assess whether DNase or Alteplase improves pleural fluid drainage in pleural infection. | ||
Medical condition: Empyema and complicated parapneumonic pleural effusion. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000358-13 | Sponsor Protocol Number: A3921187 | Start Date*: 2014-12-04 | |||||||||||
Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 3b/4 RANDOMIZED DOUBLE BLIND STUDY OF 5 MG OF TOFACITINIB WITH AND WITHOUT METHOTREXATE IN COMPARISON TO ADALIMUMAB WITH METHOTREXATE IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATO... | |||||||||||||
Medical condition: Moderately to severely active Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) EE (Completed) LT (Completed) LV (Completed) GB (Completed) ES (Completed) PL (Completed) BG (Completed) RO (Completed) DE (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003168-37 | Sponsor Protocol Number: Thllo | Start Date*: 2019-05-13 |
Sponsor Name:University Tuebingen | ||
Full Title: Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study | ||
Medical condition: Acute respiratory distress syndrome requiring mechanical ventilation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004566-14 | Sponsor Protocol Number: SanteonCAP | Start Date*: 2012-01-09 |
Sponsor Name: | ||
Full Title: Santeon-CAP study Dexamethasone in community-acquired pneumonia. | ||
Medical condition: Patients with a community-acquired pneumonia who are admitted to the hospital. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003177-99 | Sponsor Protocol Number: A3921133 | Start Date*: 2014-07-10 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: PHASE 3B/4 RANDOMIZED SAFETY ENDPOINT STUDY OF 2 DOSES OF TOFACITINIB IN COMPARISON TO A TUMOR NECROSIS FACTOR (TNF) INHIBITOR IN SUBJECTS WITH RHEUMATOID ARTHRITIS | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SE (Completed) FI (Completed) NL (Completed) SK (Completed) GB (Completed) ES (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001863-64 | Sponsor Protocol Number: AP301-II-001 | Start Date*: 2012-07-03 |
Sponsor Name:Apeptico Forschung und Entwicklung GmbH | ||
Full Title: Proof of concept study in male and female intensive care patients to investigate the clinical effect of repetitive orally inhaled doses of AP301 on alveolar liquid clearance in acute lung injury | ||
Medical condition: Acute Pulmonary oedema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000181-39 | Sponsor Protocol Number: C0168X84, EU-0108 | Start Date*: 2005-08-31 |
Sponsor Name:Med. Universitaetsklinik Graz, ao Univ. Professor Dr. med. Thomas C. Wascher | ||
Full Title: A Prospective Trial of Anti-TNF-a Chimeric Monoclonal Antibody (infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human Obesity | ||
Medical condition: Insulin Resistant Human Obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004578-27 | Sponsor Protocol Number: A3921094 | Start Date*: 2012-04-26 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, New York 10017 | |||||||||||||
Full Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) DK (Completed) HU (Completed) EE (Completed) LV (Completed) DE (Completed) BE (Completed) ES (Completed) NL (Completed) AT (Completed) SK (Completed) PL (Completed) IT (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-007185-33 | Sponsor Protocol Number: 3242K1-2000-WW | Start Date*: 2010-01-12 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals Inc. Acting through its division Wyeth Research, a Pfizer Company | |||||||||||||
Full Title: A Seamless, Phase 1/2, Multiple Ascending Dose, Proof of Concept Study of ATN-103 Administered to Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) BE (Completed) NL (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004579-35 | Sponsor Protocol Number: A3921095 | Start Date*: 2012-05-01 | |||||||||||
Sponsor Name:Pfizer Inc, 235 East 42nd Street, New York, New York 10017 | |||||||||||||
Full Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS | |||||||||||||
Medical condition: Moderate to severe active Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) HU (Completed) EE (Completed) DK (Completed) LV (Completed) BE (Completed) ES (Completed) NL (Completed) AT (Completed) DE (Completed) SK (Completed) PL (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004620-38 | Sponsor Protocol Number: 242-12-233 | Start Date*: 2019-01-14 |
Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | ||
Full Title: Phase 2, Open-label, Multiple-dose Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Delamanid (OPC 67683) in Pediatric Multidrug-resistant Tuberculosis Patients on Therap... | ||
Medical condition: Pediatric patients with multidrug-resistant tuberculosis (MDR-TB) who are receiving an optimized background regimen (OBR) of antituberculosis drugs | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2010-023782-22 | Sponsor Protocol Number: A9391010 | Start Date*: 2011-12-16 | |||||||||||
Sponsor Name:Pfizer, S.L.U. | |||||||||||||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND ASSESSMENT OF EFFICACY AND SAFETY OF PF-04171327(1, 5, 10, 15 MG DOSE, DAILY) COMPARED TO 5 MG AND 10 MG PREDNISONE DAILY AND PLACEBO DAILY IN SUBJECTS WITH RHEU... | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) DE (Completed) HU (Completed) SK (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003137-25 | Sponsor Protocol Number: ODAPE | Start Date*: 2014-12-26 |
Sponsor Name:José Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna | ||
Full Title: Optimal duration of antibiotic treatment in patients with complicated parapneumonic pleural effusions or empyema: a randomized clinical trial | ||
Medical condition: Duration of antibiotic treatment in complicated parapneumonic pleural effusion and empyema. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000398-11 | Sponsor Protocol Number: GS-US-205-0170 | Start Date*: 2015-02-03 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for t... | |||||||||||||
Medical condition: Cystic fibrosis and chronic infection of lower respiratory tract with Pseudomonas aeruginosa | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002787-26 | Sponsor Protocol Number: DINORA4 | Start Date*: 2007-01-05 |
Sponsor Name:Vienna Medical University | ||
Full Title: A Double Blind, Randomized, Placebo Controlled, Multi-Center Trial of Anti-TNFα Chimeric Monoclonal Antibody (Infliximab, Remicade®) in Combination with Methotrexate in Patients with Very Early Inf... | ||
Medical condition: Classification criteria to delineate this group of patients are not available. It is likely that patients eligible for DINORA are often not yet under rheumatologists’ care in many current clinical ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) NL (Completed) DE (Completed) ES (Completed) GR (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000586-26 | Sponsor Protocol Number: TIME3UK | Start Date*: 2009-03-20 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Adjuvant Urokinase in the Treatment of Malignant Pleural Effusion: The Third Therapeutic Intervention in Maligant Effusion Trial (TIME3-UK). A Randomised Controlled Trial to evaluate whether use of... | |||||||||||||
Medical condition: Patients with malignant pleural effusions | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002647-86 | Sponsor Protocol Number: BALTI-2, Version 2 | Start Date*: 2006-09-25 |
Sponsor Name:Heart of England NHS Foundation Trust [...] | ||
Full Title: BALTI-2: Beta Agonists in Lung Injury Trial | ||
Medical condition: Acute respiratory distress syndrome (ARDS) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-000105-65 | Sponsor Protocol Number: 1 | Start Date*: 2006-08-30 |
Sponsor Name:Medical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases | ||
Full Title: Comparative study of the efficacy and tolerance of intravenously administered azithromycin (1.5 g) given either as a single dose or over a 3 day period in patients with community-acquired pneumonia | ||
Medical condition: community aquired pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005079-17 | Sponsor Protocol Number: 06-IN-AK004 | Start Date*: 2007-02-19 | |||||||||||
Sponsor Name:Nektar Therapeutics | |||||||||||||
Full Title: An Open-Label, Multicenter, Multinational Study to Assess the Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-Ventilated Patients with Nosocomial Pne... | |||||||||||||
Medical condition: Nosocomial Pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.